What Is Known about Theragnostic Strategies in Colorectal Cancer

Despite the paradigmatic shift occurred in recent years for defined molecular subtypes in the metastatic setting treatment, colorectal cancer (CRC) still remains an incurable disease in most of the cases. Therefore, there is an urgent need for new tools and biomarkers for both early tumor diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Parisi, Alessandro, Porzio, Giampiero, Pulcini, Fanny, Cannita, Katia, Ficorella, Corrado, Mattei, Vincenzo, Delle Monache, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912746/
https://www.ncbi.nlm.nih.gov/pubmed/33535557
http://dx.doi.org/10.3390/biomedicines9020140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912746/
https://www.ncbi.nlm.nih.gov/pubmed/33535557
http://dx.doi.org/10.3390/biomedicines9020140

Ejemplares similares